Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11;18) negative, surgically resected, gastrointestinal B cell lymphomas

Journal of Clinical Pathology

Volumn 57, Issue 4, 2004, Pages 360-364

  Krugmann, J ^a   Tzankov, A ^a   Dirnhofer, S ^b   Fend, F ^c   Greil, R ^a   Siebert, R ^d   Erdel, M ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; B CELL LYMPHOMA; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CENTROMERE; CHROMOSOME 18; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 11; CHROMOSOME VARIANT; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE PROBE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MALT1 GENE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TRISOMY 18;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TRANSLOCATION, GENETIC; TRISOMY;

EID: 1842454823     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.012369     Document Type: Article

References (42)

1. Ott G, Katzenberger T, Greiner A, et al. The t(11;18) (q21;2) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT type). Cancer Res 1997;57:3944-8.
2. Dierlamm J, Baens M, Stefanova-Ouzounova M, et al. Detection of t(11;18) (q21;21) by interphase fluorescence in situ hybridization using API2 and MLT specific probes. Blood 2000;96:2215-18.
3. Remstein ED, James CD, Kurtin PJ. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 2000;156:1183-8.
4. Kalla J, Stilgenbauer S, Schaffner C, et al. Heterogeneity of the API2-MALT1 gene rearrangement in MALT type lymphoma. Leukemia 2000;14:1967-74.
5. Baens M, Steyls A, Dierlamm J, et al. Structure of the MLT gene and molecular characterization genomic breakpoint junctions in the t(11;18)(q21;21) of marginal zone B-cell lymphomas of MALT type. Genes Chromosomes Cancer 2000;29:281-91.
6. Motegi M, Yonezumi M, Suzuki H, et al. API2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products. Am J Pathol 2000;156:807-12.
7. Liu H, Ye H, Dogan A, et al. T(11;18)(q21;21) is associated with advanced mucosa-associated lymphoid tissue lymphomas that express nuclear bcl-10. Blood 2001;98:1182-7.
8. Inagaki H, Okabe M, Seto M, et al. API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma. Multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimens. Am J Pathol 2001;158:699-706.
9. Kobayashi Y, Nakata M, Maekawa M, et al. Detection of t(11;18) in MALT lymphoma with dual fluorescence in situ hybridization and reverse transcriptase-polymerase chain reaction analysis. Diagn Mol Pathol 2001;10:207-13.
10. Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 2002;99:3-9.
11. Barth TFE, Bentz M, Leithäuser F, et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer 2001;31:316-25.
12. Hoeve MA, Gisbertz IA, Schouten HC, et al. Gastric low-grade MALT lymphoma, high grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia 1999;13:799-807.
13. Remstein ED, Kurtin PJ, James CD, et al. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am J Pathol 2002;161:63-71.
14. Krugmann J, Dirnhofer S, Gschwendtner A, et al. Primary gastrointestinal B-cell Tymphoma - a clinicopathological and immunohistochemical study of 61 cases with evaluation of prognostic parameters. Pathol Res Pract 2001;197:385-93.
15. Harris NL, Jaffe K, Diebold, et al. The World Health Organisation classification of hematological malignancies report of the clinical advisory committee meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000;13:193-207.
16. Mushoff K. Stadieneinteilung der Nicht-Hodgkin-Lymphome. Strahlentherapie 1977;153:218-22.
17. Montesinos-Rongen M, Zühlke-Jenisch R, Gesk S, et al. Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system. J Neuropathol Exp Neurol 2002;61:926-33.
18. Sanchez-Izquierdo D, Buchonnet G, Siebert R, et al. MLT is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin's lymphoma. Blood 2003;101:4539-46.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
20. Petö R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;39:1-39.
21. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-4.
22. Ott G, Kalla J, Steinhoff A, et al. Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol 1998;153:689-94.
23. Skacel M, Paris PL, Pettay JD, et al. Diffuse large B-cell lymphoma of the stomach: assessment of microsatellite instability, allelic imbalance, and trisomy of chromosomes 3, 12 and 18. Diagn Mol Pathol 2002;11:75-82.
24. Dierlamm J, Michaux L, Wlodarska I, et al. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytogenetic analysis and fluorescence in situ hybridization. Br J Haematol 1996;93:242-9.
25. Brynes RK, Almaguer PD, Leathery KE, et al. Numerical cytogenetic abnormalities of chromosomes 3, 7 and 12 in marginal zone B-cell lymphomas. Mod Pathol 1996;9:995-100.
26. Zhang Y, Cheung ANY, Chan ACL, et al. Detection of trisomy 3 in primary gastric B-cell lymphomas. Am J Clin Pathol 1997;110:347-53.
27. Blanco R, Lyda M, Davis B, et al. Trisomy 3 in gastric lymphomas of extranodal marginal zone B-cell (mucosa-associated lymphoid tissue) origin demonstrated by FISH in intact paraffin tissue sections. Hum Pathol 1999;30:706-11.
28. Dragosics B, Bauer P, Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathological study of 150 cases. Cancer 1985;55:1060-70.
29. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991;101:1159-70.
30. Nakamura S, Akazawa K, Yao T, et al. Primary gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer 1995;76:1314-24.
31. Green JA, Dawson AA, Lessells AM, et al. Prognostic factors in gastrointestinal lymphoma. Clin Oncol 1981;17:115-21.
32. Aozasa K, Tsujimoto M, Inoue A, et al. Primary gastrointestinal lymphoma: a clinicopathological study of 102 patients. Oncology 1985;42:97-103.
33. Joensuu H, Söderström KO, Klemi PJ, et al. Nuclear DNA content and its prognostic value in lymphoma of the stomach. Cancer 1987;60:3042-8.
34. Azab MB, Henry-Amar M, Rougier P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin's lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer 1989;64:1208-17.
35. Okuda A, Suzuki H. Effects of DNA ploidy patterns on the survival of patients with primary gastrointestinal lymphoma. Jpn J Surg 1996;26:586-90.
36. Ferreri AJ, Freschi M, Dell Oro S, et al. Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas. Am J Surg Pathol 2001:25:95-102.
37. Takeshita M, Iwashita A, Kurihara K, et al. Histologic and immunohistologic findings and prognosis of 40 cases of gastric large cell lymphoma. Am J Surg Pathol 2001;24:1641-9.
38. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992;102:1628-38.
39. Taal BG, Boot H, van Heerde P, et al. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut 1996;39:556-61.
40. de Jong D, Boot H, van Herde, et al. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997;112:1466-74.
41. Ranaldi R, Gateri G, Baccarini MG, et al. A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. J Clin Pathol 2002;55:346-51.
42. Du M, Peng H, Singh N, et al. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995;86:4587-93.